- Home
- PSHG vs PRPH Comparison
PSHG vs PRPH Comparison
Compare PSHG & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSHG
- PRPH
- Stock Information
- Founded
- PSHG 2010
- PRPH 1989
- Country
- PSHG Greece
- PRPH United States
- Employees
- PSHG N/A
- PRPH N/A
- Industry
- PSHG Marine Transportation
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- PSHG Consumer Discretionary
- PRPH Health Care
- Exchange
- PSHG Nasdaq
- PRPH Nasdaq
- Market Cap
- PSHG 25.2M
- PRPH 21.9M
- IPO Year
- PSHG N/A
- PRPH 1997
- Fundamental
- Price
- PSHG $2.00
- PRPH $0.39
- Analyst Decision
- PSHG
- PRPH
- Analyst Count
- PSHG 0
- PRPH 0
- Target Price
- PSHG N/A
- PRPH N/A
- AVG Volume (30 Days)
- PSHG 125.2K
- PRPH 1.6M
- Earning Date
- PSHG 11-07-2025
- PRPH 11-12-2025
- Dividend Yield
- PSHG N/A
- PRPH N/A
- EPS Growth
- PSHG 5.84
- PRPH N/A
- EPS
- PSHG 1.56
- PRPH N/A
- Revenue
- PSHG $84,042,000.00
- PRPH $5,588,000.00
- Revenue This Year
- PSHG N/A
- PRPH $221.82
- Revenue Next Year
- PSHG $17.95
- PRPH N/A
- P/E Ratio
- PSHG $1.29
- PRPH N/A
- Revenue Growth
- PSHG N/A
- PRPH N/A
- 52 Week Low
- PSHG $1.31
- PRPH $0.22
- 52 Week High
- PSHG $2.34
- PRPH $2.40
- Technical
- Relative Strength Index (RSI)
- PSHG 59.11
- PRPH 41.28
- Support Level
- PSHG $1.98
- PRPH $0.35
- Resistance Level
- PSHG $2.16
- PRPH $0.40
- Average True Range (ATR)
- PSHG 0.09
- PRPH 0.05
- MACD
- PSHG 0.01
- PRPH -0.02
- Stochastic Oscillator
- PSHG 51.66
- PRPH 18.68
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.